References
-
Byun SW, Lee A, Kim S, Choi YJ, Lee YS, Park JS. Immunostaining of
$p16^{INK4a}$ /Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases. Int J Med Sci. 2013, 10:1602-1607. https://doi.org/10.7150/ijms.6526 - Choi SK, Kim TJ, Hong SB, Lee HT. Expression of p53 and Ki-67 in cervical dysplasia with human papilloma virus infection or non-infection. Korean J Clin Lab Sci. 2004, 36(2):178-184.
- Dona MG, Vocaturo A, Giuliani M, Ronchetti L, Rollo F, Pescarmona E, et al. p16/ Ki-67 dual staining in cervico-vaginal cytology: correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy. Gynecol Onocol. 2012, 126:198-202. https://doi.org/10.1016/j.ygyno.2012.05.004
- Edgerton N, Cohen C, Siddiqui MT. Evaluation of CINtec PLUS Testing as an adjunctive test in ASC-US diagnosed Surepath preparations. Diagn Cytopathol. 2013, 41: 35-40. https://doi.org/10.1002/dc.21757
- Ikenberg H, Bergeron C, Schmidt D, Griesser H, Alameda F, Angeloni C, et al. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study. J Natl Cancer Inst. 2013, 105:1550-1557. https://doi.org/10.1093/jnci/djt235
- Keating JT, Ince T, Crum CP. Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis. Adv Anat Pathol. 2001, 8:83-92. https://doi.org/10.1097/00125480-200103000-00004
- Keating JT, Cviko A, Riethdorf, Riethdrof L, Quade BJ, Sun D, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol. 2001, 25:884-891. https://doi.org/10.1097/00000478-200107000-00006
- Kim MY, Cho SH, Park MH. Analysis of expression of p63 incervical neoplasia comparing with other immunohistochemical markers. Korean J Pathol. 2003, 37:333-341.
- Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, et al. Overexpression of p16(INK4a) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001, 92:276-284. https://doi.org/10.1002/ijc.1174
- Kruse AJ, Jansen EA, Kjellevold KH, Lovesiett K, Bergh J, Bergh J, et al. Ki-67 predicts progression in early CIN. Validation of a multivariate progression risk mode. Cell Oncol. 2004, 26:13-20.
- Kwon MJ, Song EJ, Kim CW, Hong SN, Eum ST. The significance of Human Papilloma viral load by using hybrid capture II assay in diagnosis of CIN II or above in women with PAP smear showing only ASCUS/LSIL. Obstet Gynecol Sci. 2005, 12: 2867-2876.
- Lee KO, Seong HS, Chung SJ, Jung NY, Lee HJ, Kim KT. Genotype Frequency of Human Papillomavirus Determined by PCR and DNA Sequencing in Korean Women. Korean J Clin Lab Sci. 2006, 27(2):99-105.
- Lim HS, Kim MJ, Park KE, Chung HH, Park NH, Song YS, et al. The efficacy of a real-time optoelectronic device as a diagnostic tool of over cervical intraepithelial neoplasia 1 lesion. Obstet Gynecol Sci. 2010, 10:888-89.
- National cancer center. Annual report of cancer statistics in Korea in 2011 [Internet]. Available from: http://www.cancer.go.kr/cms/statics/incidence/index. html, last visited on 2014 January 26.
- Nucci MR, Castrillon DH, Bai H, Quade BJ, Ince TA, Genest DR, et al. Biomarkers in diagnostic obstetric and gynecologic pathology: A review. Adv Anat Pathol. 2003, 10: 55-68. https://doi.org/10.1097/00125480-200303000-00001
- Overstad IT, Vennestrom U, Andersen L, Gudlaugsson E, Munk AC, Malpica A, et al. Comparison of different commercial methods for HPV detection in follow upbiopsies and spontaneous regression of CIN 2-3. Gynecol Oncol. 2011, 123:278-283. https://doi.org/10.1016/j.ygyno.2011.07.024
- Petry KU, Schmidt D, Scherbring S, Luyten A, Reinecke-Luthge A, Bergeron C, et al. Triaging pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dualstained cytology. Gynecol Oncol. 2011, 121:505-509. https://doi.org/10.1016/j.ygyno.2011.02.033
-
Reuschenbach M, Clad A, von Knebel Doeberitz C, Wentzensen N, Rahmsdorf J, Schaffrath F, et al. Performance of
$p16^{INK4a}$ -cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia I women with abnormal screening results. Gynecol Oncol. 2010, 199: 98-105. - Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol. 1998, 153:1741-1748. https://doi.org/10.1016/S0002-9440(10)65689-1
- Schmidt D, Beraeron C, Denton KJ, Ridder R. p16/Ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology results from the European equivocal or midly abnormal Papanicolaou cytolgy study. Cancer Cytopathol. 2011, 119:158-166. https://doi.org/10.1002/cncy.20140
- Stanley MA. Prognostic factors and new therapeutic approaches to cervical cancer. Virus Res. 2002, 89:241-248. https://doi.org/10.1016/S0168-1702(02)00192-2
- Stoler MH, Schiffman M. Interobsever reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL triage study. JAMA. 2001, 285:1500-1505. https://doi.org/10.1001/jama.285.11.1500
- Szarewski A, Mesher D, Cadman L, Austin J, Ashdown-Barr L, Ho L, et al. Comparison of seven test for high-grade cervical intraepithelial neoplasia in women with abnormal smears. J Clin Microbiol. 2012, 50:1867-1873. https://doi.org/10.1128/JCM.00181-12
- Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, et al. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012, 18:4154-4162. https://doi.org/10.1158/1078-0432.CCR-12-0270
-
Waldstrom M, Christensen RK, Omskov D. Evaluation of
$p16^{INK4a}$ /Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with lowgrade squamous intraepithelial lesion. Cancer Cytopathol. 2013, 121:136-145. https://doi.org/10.1002/cncy.21233 -
Yeo SJ, Nam KH, Shim IK, Kim TH, Lee KH, Kim HM, et al. Overexpression of
$p16^{INK4a}$ as a biomarker for ASCUS in Thin PrepTM smear. J Gynecol Oncol. 2005, 16(2):141-147. https://doi.org/10.3802/kjgo.2005.16.2.141 -
Yoshida T, Sano T, Kanuma T, Inoue H, Itoh T, Yazaki C, et al. Usefulness of
$CINtec^{(R)}$ PLUS p16/Ki-67 double-staining in cytological screening of cervical cancer. Acta cytol. 2011, 55(5): 413-420. https://doi.org/10.1159/000331047 - Zappacosta R, Colasante A, Viola P, D' Antuono T, Lattanzio G, Capanna S, et al. Chromogenic in situ hybridization and p16/ Ki-67 dual staining on formalin-fixed paraffin-embedded cervical specimens: Correlation with HPV-DNA test, E6/E7 mRNA test, and potential clinical applications. Biomed Res Int. 2013, 2013:453-606.
Cited by
- 다발성골수종 환자의 파라핀포매조직에서 MicroRNA 발현 vol.47, pp.4, 2015, https://doi.org/10.15324/kjcls.2015.47.4.292